DKSH provides commercialisation services for healthcare companies wishing to enter the Asian market. Our service offering includes regulatory affairs, manufacturing, marketing and distribution. We can help companies develop market entry strategies for their brands in Asian markets and provide the resources to execute the strategy.

DKSH are the only fully integrated service partner operating Asia wide and are the ideal partner if companies are focussing on entering this dyanamic fast growing market.

DKSH are looking to partner with companies wishing to establish their pharmaceutical brands in the Asian market place. We are flexible in our approach to partnering strategies and will work with companies to develop the most appropriate business model. These could include in-licensing, co-investment models and joint ventures.